Dronabinol Market Forecast Driven by Pharmaceutical Demand and Formulation Innovation | Valuates Reports

Dronabinol Market Size
The global market for Dronabinol was valued at US$ 272 million in the year 2024 and is projected to reach a revised size of US$ 418 million by 2031, growing at a CAGR of 6.4% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-23T8829/Global_Dronabinol_Market_Outlook_2022

The dronabinol market is experiencing steady market growth, fueled by its established role in managing chemotherapy-induced nausea, appetite stimulation in chronic conditions, and expanding therapeutic exploration. The market size continues to broaden as the pharmaceutical industry advances formulations and regulatory acceptance strengthens across regions.

By type, synthetic dronabinol retains the larger market share, supported by its consistent purity, scalable manufacturing processes, and broad regulatory approvals. Natural dronabinol, while currently accounting for a smaller share, is the faster-growing segment, reflecting a consumer trend toward plant-derived alternatives and rising interest in botanical sourcing.

In application, capsule formulations dominate the market size due to their ease of use, dosage control, and prevalence in clinical settings. Oral liquid forms, despite a smaller share, demonstrate the strongest growth trajectory as they offer flexible dosing options, better absorbability, suitability for pediatric and geriatric patients, and alignment with telemedicine and at-home treatment trends.

Overall, the dronabinol market forecast suggests continued market growth, bolstered by increasing therapeutic adoption, advanced formulation development, and growing patient and provider acceptance of both synthetic and natural alternatives options in modern medical treatments.

Segment by Type

• Synthetic Dronabinol
• Natural Dronabinol

Segment by Application

• Capsule
• Oral Liquid

By Company

Canopy Growth, Noramco, KinetoChem, Entourage Phytolab, Echo Pharmaceuticals, BOL Pharma, Aphios Corporation, Benuvia Manufacturing

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-23T8829/global-dronabinol

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.